Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Zolla-Pazner: Epitope-Scaffold Immunogens |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2011-08-02 |
| Study Made Public: | 2012-06-11 |
Title
Zolla-Pazner VDC_Zolla-Pazner_NYU-12
Description
CAVD 269 (NYU-12) is a preclinical rabbit study comparing immunization regimens with and without DNA priming using gp140-CN54 or (V3C-V3 + V33074-CTB) protein immunogens.
Sign in to see full information about this study and to download study data.
Products
IFA DNA (gp120.C1-opt) V3/3074 CTB V3/C gp140 CN54Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.